{"pmid":32383251,"title":"The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.","text":["The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.","Dermatol Ther","Shah, Monica","Sachdeva, Muskaan","Dodiuk-Gad, Roni P","32383251"],"journal":"Dermatol Ther","authors":["Shah, Monica","Sachdeva, Muskaan","Dodiuk-Gad, Roni P"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32383251","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/dth.13524","keywords":["covid-19","coronavirus","dermatomyositis","hydroxychloroquine","shortage","treatment"],"e_drugs":["Hydroxychloroquine"],"topics":["Prevention"],"weight":1,"_version_":1666419683205578752,"score":9.490897,"similar":[{"pmid":32434820,"title":"Hydroxychloroquine shortages during the COVID-19 pandemic.","text":["Hydroxychloroquine shortages during the COVID-19 pandemic.","Ann Rheum Dis","Mendel, Arielle","Bernatsky, Sasha","Thorne, J Carter","Lacaille, Diane","Johnson, Sindhu R","Vinet, Evelyne","32434820"],"journal":"Ann Rheum Dis","authors":["Mendel, Arielle","Bernatsky, Sasha","Thorne, J Carter","Lacaille, Diane","Johnson, Sindhu R","Vinet, Evelyne"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434820","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217835","keywords":["antirheumatic agents","autoimmune diseases","epidemiology","hydroxychloroquine","lupus erythematosus, systemic"],"e_drugs":["Hydroxychloroquine"],"topics":["Prevention"],"weight":1,"_version_":1667521393556717568,"score":67.867294},{"pmid":32444414,"title":"Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.","text":["Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.","Ann Rheum Dis","Megremis, Spyridon","Walker, Thomas D J","He, Xiaotong","Ollier, William E R","Chinoy, Hector","Hampson, Lynne","Hampson, Ian","Lamb, Janine A","32444414"],"journal":"Ann Rheum Dis","authors":["Megremis, Spyridon","Walker, Thomas D J","He, Xiaotong","Ollier, William E R","Chinoy, Hector","Hampson, Lynne","Hampson, Ian","Lamb, Janine A"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444414","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217522","keywords":["autoantibodies","autoimmune diseases","dermatomyositis"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1667600475944386560,"score":65.90063},{"pmid":32434826,"title":"Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al.","text":["Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al.","Ann Rheum Dis","McInnes, Iain","32434826"],"journal":"Ann Rheum Dis","authors":["McInnes, Iain"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434826","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/annrheumdis-2020-217954","keywords":["hydroxychloroquine","immune complex diseases","inflammation"],"e_drugs":["Hydroxychloroquine"],"weight":0,"_version_":1667521393586077696,"score":59.861385},{"pmid":32502485,"title":"Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.","text":["Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.","Am J Med","Shih, Richard D","Johnson, Heather M","Maki, Dennis G","Hennekens, Charles H","32502485"],"journal":"Am J Med","authors":["Shih, Richard D","Johnson, Heather M","Maki, Dennis G","Hennekens, Charles H"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502485","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.amjmed.2020.05.005","keywords":["coronavirus","hydroxychloroquine","treatment"],"topics":["Treatment"],"weight":1,"_version_":1668804508679929856,"score":58.11888},{"pmid":32322402,"pmcid":"PMC7171523","title":"Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.","text":["Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.","Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses.","New Microbes New Infect","Saqrane, S","El Mhammedi, M A","32322402"],"abstract":["Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses."],"journal":"New Microbes New Infect","authors":["Saqrane, S","El Mhammedi, M A"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322402","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.nmni.2020.100680","keywords":["chloroquine","covid-19","coronavirus","epidemic","hydroxychloroquine","treatment"],"e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138493770792960,"score":56.73658}]}